Intriguingly, as shown in Table 1, we established a significant negative correlation between GATA6 expression levels and crucial clinicopathological parameters, including tumor volume (Fig. 1F), lymph node metastasis (Fig. 1G), and clinical staging of patients (Fig. 1H). This evidence concerns the gene GATA6 and neoplasm.